The effects of gestational age and birth weight on false-positive newborn-screening rates

Pediatrics

Volumn 126, Issue 5, 2010, Pages 910-916

  Slaughter, Jonathan L ^a,c   Meinzen Derr, Jareen ^a   Rose, Susan R ^a   Leslie, Nancy D ^a   Chandrasekar, Ram ^b   Linard, Sharon M ^b   Akinbi, Henry T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Ohio Department   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

17 hydroxyprogesterone; Neonatal intensive care; Newborn screening; Preterm infant; Public health; Tandem mass spectrometry; Thyroid stimulating hormone; Thyroxine

Indexed keywords

HYDROXYPROGESTERONE; THYROTROPIN; THYROXINE;

ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; FALSE POSITIVE RESULT; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; UNITED STATES; VERY LOW BIRTH WEIGHT;

17-ALPHA-HYDROXYPROGESTERONE; BIRTH WEIGHT; FALSE POSITIVE REACTIONS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; NEONATAL SCREENING; REFERENCE VALUES; THYROTROPIN; THYROXINE;

EID: 78049434721     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-0943     Document Type: Article

References (30)

1. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338-343
2. Wilcken B, Haas M, Joy P, et al. Expanded newborn screening: Outcome in screened and unscreened patients at age 6 years. Pediatrics. 2009;124(2):e241-e248
3. Carroll AE, Downs SM. Comprehensive costutility analysis of newborn screening strategies. Pediatrics. 2006;117(5 pt 2):S287-S295 (Pubitemid 46071316)
4. Kwon C, Farrell PM. The magnitude and challenge of false-positive newborn screening test results. Arch Pediatr Adolesc Med. 2000;154(7):714-718 (Pubitemid 30437554)
5. Tarini BA, Christakis DA, Welch HG. State newborn screening in the tandem mass spectrometry era: More tests, more false-positive results. Pediatrics. 2006;118(2):448-456
6. Kaye CI, Committee on Genetics, Accurso F, et al. Introduction to the newborn screening fact sheets. Pediatrics. 2006;118(3):1304-1312
7. American Academy of Pediatrics, Rose SR, Section on Endocrinology and Committee on Genetics, American Thyroid Association, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006;117(6):2290-2303
8. King JL, Naber JM, Hopkin RJ, Repaske DR, Bailey L, Leslie ND. Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia. Arch Pediatr Adolesc Med. 2001;155(9):1038-1042
9. Gatelais F, Berthelot J, Beringue F, et al. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: Implication for neonatal screening of congenital adrenal hyperplasia. Pediatr Res. 2004;56(5):701-705 (Pubitemid 39403393)
10. Miller J, Tuerck J,AwadK, et al.NewbornScreening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline. Wayne, PA: Clinical and Laboratory Standards Institute; 2009. CLSI document I/LA31-A. Available at: www.clsi.org/source/orders/free/ILA31-A.pdf. Accesses September 13, 2010
11. Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med. 2003;348(23):2304-2312 (Pubitemid 36638104)
12. Schulze A, Lindner M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann GF. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: Results, outcome, and implications Pediatrics. 2003;111(6 pt 1):1399-1406 (Pubitemid 36682277)
13. Zaffanello M, Maffeis C, Zamboni G. Multiple positive results during a neonatal screening program: A retrospective analysis of incidence, clinical implications and outcomes. J Perinat Med. 2005;33(3):246-251 (Pubitemid 41069868)
14. Zaffanello M, Zamboni G, Maffeis C, Tatò L. Neonatal birth parameters of positive newborns at PKU screening as predictors of false-positive and positive results at recall-testing. J Med Screen. 2003;10(4):181-183 (Pubitemid 38091204)
15. Dhondt JL. Prematurity and neonatal screening. Arch Pediatr. 2008;15(Suppl 1):S7-S11
16. Ohio Department of Health. Newborn Screening Program. Columbus, OH: Ohio Department of Health; 2006. Available at: www.odh.ohio.gov/odhPrograms/phl/ newbrn/nbrn1.aspx. Accessed July 29, 2010
17. Wilcken B. Recent advances in newborn screening. J Inherit Metab Dis. 2007;30(2):129-133
18. Eunice Kennedy Shriver National Institute of Child Health and Human Development. Neonatal Research Network. Bethesda, MD: National Institutes of Health; 2010. Available at: neonatal.rti.org. Accessed July 29, 2010
19. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365(9477):2125-2136
20. Zamboni G, Zaffanello M, Rigon F, Radetti G, Gaudino R, Tatò L. Diagnostic effectiveness of simultaneous thyroxine and thyroid-stimulating hormone screening measurements: thirteen years' experience in the Northeast Italian Screening Programme. J Med Screen. 2004;11:8-10 (Pubitemid 38365688)
21. Lott JA, Sardovia-Iyer M, Speakman KS, Lee KK. Age-dependent cutoff values in screening newborns for hypothyroidism. Clin Biochem. 2004;37(9):791-797 (Pubitemid 39141121)
22. Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. J Pediatr. 1997;130(1):128-133 (Pubitemid 27492730)
23. Olgemoller B, Roscher AA, Liebl B, Fingerhut R. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value. J Clin Endocrinol Metab. 2003;88(12):5790-5794 (Pubitemid 38033052)
24. Sorenson JR, Levy HL, Mangione TW, Sepe SJ. Parental response to repeat testing of infants with "false-positive" results in a newborn screening program. Pediatrics. 1984;73(2):183-187
25. Waisbren SE, Albers S, Amato S, et al. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA. 2003;290(19):2564-2572 (Pubitemid 37443286)
26. Gurian EA, Kinnamon DD, Henry JJ, Waisbren SE. Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics. 2006;117(6):1915-1921
27. Balk KG. Recommended newborn screening policy change for the NICU infant. Policy Polit Nurs Pract. 2007;8(3):210-219
28. Kirpalani H, Whyte RK, Andersen C, et al. The premature infants in need of transfusion (PINT) study: A randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006;149(3):301-307 (Pubitemid 44308431)
29. Whyte RK, Kirpalani H, Asztalos EV, et al. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics. 2009;123(1):207-213
30. Valieva OA, Strandjord TP, Mayock DE, Juul SE. Effects of transfusions in extremely low birth weight infants: a retrospective study. J Pediatr. 2009;155(3):331.e1-337.e1